Since its founding in 2008 to honor the life and wishes of Henry Schueler, the Henry Schueler 41&9 Foundation has raised more than $1 million to support our mission of advancing research to conquer the medical challenges of pediatric leukemia, specifically high-risk acute lymphoblastic leukemia, and fungal infections such as Mucormycosis.
We have established strong partnerships with medical pioneers at leading institutions such as Dr. Charles Mulligan of St. Jude’s Children’s Research Hospital; Dr. Steven Hunger, Chief of the Division of Oncology and Director Center for Childhood Cancer Research at the Children’s Hospital of Philadelphia; and Dr. Thomas Walsh of New York Presbyterian/Weill Cornell Hospital.
The Foundation remains dedicated to funding groundbreaking research that makes a profound impact on children affected. By supporting medical advancements and treatment strides, we steadfastly move toward Henry’s wish that the challenges associated with pediatric leukemia and fungal infections “do not happen to other kids.”
Help Us: “Stay Strong – we’re going to beat this thing.”